A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
Clinical trial NCT00122850 · COMPLETED
Trial details
- NCT number
- NCT00122850
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.